Use of dose volume parameters in brachytherapy for prostate and gynaecology

C. Kirisits , M. Moerland
Radiotherapy and Oncology 81

2006
OC-0569: Incidence of severe gastrointestinal and urinary fistulas, bleeding and strictures: EMBRACE results

K. Tanderup , K. Bruheim , C. Kirisits , E. Van Limbergen
Radiotherapy and Oncology 152

2020
OC-0680: Risk factors for urinary incontinence in locally advanced cervix cancer: an EMBRACE analysis

K. Tanderup , K. Bruheim , C. Kirisits , E. Van Limbergen
Radiotherapy and Oncology 152

2020
PH-0404: Risk factors for late diarrhoea after radio(chemo)therapy in cervical cancer: EMBRACE I results

K. Tanderup , C. Chargari , K. Bruheim , C. Kirisits
Radiotherapy and Oncology 152

2020
OC-0437: MRI guided adaptive brachytherapy in locally advanced cervical cancer: overall results of EMBRACE I

K. Tanderup , K. Bruheim , C. Kirisits , E. Van Limbergen
Radiotherapy and Oncology 152

2020
Irradiated Volumes in Image Guided Adaptive Brachytherapy in Cervix Cancer: Results from the EMBRACE Study

M. Serban , C. Kirisits , K. Nkiwane , I. Dumas
International Journal of Radiation Oncology Biology Physics 99 ( 2)

2017
Abstracts der 3. Gemeinsamen Brachytherapiekonferenz SASRO/DEGRO/OEGRO

B. Pollow , M. Kontova , N. Zamboglou , O. Ott
Strahlentherapie Und Onkologie 180 ( 1) 109 -128

2004
Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients

G. Goldner , R. Pötter , J.J. Battermann , M.P. Schmid
Strahlentherapie Und Onkologie 188 ( 4) 305 -310

25
2012
Feasibility of transrectal ultrasonography for assessment of cervical cancer.

M.P. Schmid , R. Pötter , P. Brader , A. Kratochwil
Strahlentherapie Und Onkologie 189 ( 2) 123 -128

34
2013
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study

J. Knoth , R. Pötter , I.M. Jürgenliemk-Schulz , C. Haie-Meder
Gynecologic Oncology 159 ( 1) 136 -141

3
2020
Image-guided Adaptive Brachytherapy for Cervix Carcinoma

R. Pötter , E. Fidarova , C. Kirisits , J. Dimopoulos
Clinical Oncology 20 ( 6) 426 -432

45
2008
87 A calculation model for dose-volume histograms based on serial intravascular ultrasound: Application for radioactive stents

C. Kirisits , P. Wexberg , E. Ortmann , M. Gottsauner-Wolf
Radiotherapy and Oncology 55 51

2000
PO-271 TRANSRECTAL ULTRASOUND FOR THE ASSESSMENT OF CERVIX CANCER IN THE COURSE OF PRIMARY RADIOCH EMOTHERAPY

M. Schmid , R. Potter , P. Brader , A. Kratochwil
Radiotherapy and Oncology 103

2012
LOADING PATTERNS USED DURING 10 YEARS FOR MRI BASED TREATMENT PLAN OPTIMIZATION OF 254 CERVICAL CANCER BRACHYTHERAPY PATIENTS

P. Trnkova , J. Dimopoulos , R. Pötter , C. Kirisits
Radiotherapy and Oncology 92

2009
OC-0263: Brachytherapy vaginal dose de-escalation in locally advanced cervical cancer

S. Mohamed , J.C. Lindegaard , A. De Leeuw , I.M. Jürgenliemk-Schulz
Radiotherapy and Oncology 111

2
2014
SP-0198: ICRU guidelines for gynaecological brachytherapy

C. Kirisits , R. Pötter , On behalf of the Committee
Radiotherapy and Oncology 111

2014
OC-0264: Impact of inhomogeneity corrected dose calculation on dosimetric quality parameters in gynaecological cases

J. Hofbauer , N. Nesvacil , A. Sturdza , R. Pötter
Radiotherapy and Oncology 111

2014
OC-0262: Evaluation and comparison of a novel vaginal dose reporting method in 153 cervical cancer patients

H. Westerveld , A. De Leeuw , K. Kirchheiner , P. Dankulchai
Radiotherapy and Oncology 111

2014